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Aims: To characterize the functionality of the Lactobacillus casei BL23 fbpA 
gene encoding a putative fibronectin-binding protein 
Methods and Results: Adhesion tests showed that L. casei BL23 binds 
immobilized and soluble fibronectin in a protease sensitive manner. A mutant 
with inactivated fbpA showed a decrease in binding to immobilized fibronectin 
and a strong reduction in the surface hydrophobicity as reflected by microbial 
adhesion to solvents test. However, minor effects were seen on adhesion to the 
human Caco-2 or HT-29 cell lines. Purified 6X(His)FbpA bound to immobilized 
fibronectin in a dose-dependent manner. Western blot experiments with FbpA-
specific antibodies showed that FbpA could be extracted from the cell surface 
by LiCl treatment and that protease digestion of the cells reduced the amount of 
extracted FbpA. Furthermore, surface exposition of FbpA was detected in other 
L. casei strains by LiCl extraction and whole-cell ELISA analysis. 
Conclusions: FbpA can be found at the L. casei BL23 surface and participates 
in cell attachment to immobilized fibronectin. We showed that FbpA is an 
important, but not the only, factor contributing to fibronectin binding in BL23 
strain. 
Significance and Impact of the Study: This is the first report showing the 
involvement of FbpA in fibronectin binding in L. casei BL23 and represents a 
new contribution to the study of attachment factors in probiotic bacteria. 
 
KEYWORDS: Lactobacillus casei, adhesion, fibronectin, extracellular matrix, 
probiotics 
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Lactobacilli have been used for the fermentation of food products and they have 
attracted much attention as probiotic bacteria for their beneficial effects on 
human health. Adhesion of probiotic bacteria to the host intestinal epithelium is 
an important criterion for strain selection and several methods (binding to 
cultured epithelial cells, to immobilized tissue components or to resected tissue) 
have been employed for characterization and screening of new strains 
(Ouwehand et al. 2001; Styriak et al. 2003; Tuomola and Salminen 1998; 
Vesterlund et al. 2006). Adhesion is believed not only to play a role in the 
persistence of a particular strain in the digestive tract but also to participate in 
pathogen exclusion by competition and blocking of their binding sites at the 
mucosa (Collado et al. 2007; Lee et al. 2003; Vesterlund et al. 2006). Also, it 
may contribute to immunomodulation (Galdeano et al. 2007). However, some 
authors have hypothesized that attachment factors in lactic acid bacteria are 
risk factors that might be an indicative of their pathogenic potential (Vesterlund 
et al. 2007). 
Lactobacilli can bind to mucin, a component of the mucus epithelial layer and to 
a variety of proteins present in the extracellular matrix (ECM), such as 
fibronectin, collagen and laminin, which are shed into the mucus or can be 
exposed to the intestinal lumen in case of trauma, infection or inflammation 
(Lorca et al. 2002; Styriak et al. 2003). While in most cases protein factors have 
been identified as responsible for this attachment, with the exception of mucin-
binding proteins from lactobacilli, information about specific binding proteins is 
still scarce for this group of microorganisms (Vélez et al. 2007).  
Fibronectin is a dimeric 454-kDa glycosylated protein which is present in soluble 
form in plasma and in immobilized form on the host cells surfaces and in the 
ECM. It is an important target for bacterial attachment in many pathogens, such 
as Streptococcus pneumoniae and Streptococcus pyogenes, where fibronectin-
binding proteins are important pathogenic factors (Holmes et al. 2001; 
Jedrzejas 2007; Molinari et al. 1997). There are numerous works describing the 
attachment of lactic acid bacteria to fibronectin but information about molecules 
implicated in the mechanism of binding is limited. The surface layer protein 
(SlpA) from Lactobacillus brevis ATCC8287 is involved in fibronectin binding (de 
Leeuw et al. 2006). Moreover, inspection of lactobacilli genome sequences 
reveals that they carry genes encoding proteins homologous to fibronectin 
binding proteins from streptococci. Lactobacillus casei is a species widely used 
in the dairy industry. It is also a normal constituent of the intestinal microbiota in 
humans and probiotic capacities have been reported for many strains, for which 
it is included as a probiotic in food products. Some L. casei strains survive the 
passage through the digestive tract in humans and persist in it for several days 
(Oozeer et al. 2006). In this work we sought to analyze factors involved in 
interaction with host cells and colonization of intestinal mucosa in L. casei BL23. 
This strain has been widely used for genetic and physiology studies (Acedo-
Felix andPerez-Martinez 2003), it showed anti-inflammatory effects in animal 
inflammatory bowel disease models (Foligne et al. 2007) and its genome 
sequence is available. We describe the characterization of a gene encoding a 
fibronectin-binding protein that was detected during the in silico analysis of 
putative adhesion factors encoded in the L. casei BL23 genome.  
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Strains and growth conditions 
Lactobacillus casei strains are listed in Table 1 and were grown in MRS broth 
(BD Difco, Le Pont de Claix, France) at 37ºC under static conditions. 
Escherichia coli DH5α was used for gene cloning and E. coli M15[pREP4] was 
used for protein purification. Both strains were grown in LB medium under 
agitation (200 rpm) at 37ºC. Ampicillin and kanamycin were used for E. coli at 
100 and 25 μg ml-1, respectively. Erythromycin was used for L. casei at 5 μg 
ml-1. Solid medium was prepared by adding 1.8% agar. Bacterial growth curves 
were determined in microtiter plates (200 μl MRS broth per well) at 37ºC in a 
Polarstar Omega plate reader (BMG Labtech, Offenburg, Germany). 
Construction of an L. casei BL23 fbpA mutant 
A 600-bp internal DNA fragment from the fbpA gene (LCABL_16620) was 
amplified by PCR using oligonucleotides FBP1 (5’-
CTTAAGCTTCGCAGCGTTGTTGC) and FBP2 (5’-
TGAGGTACC
15 
TGGGCAACGGCATTAC), which introduced HindIII and KpnI 
restriction sites (underlined), using L. casei BL23 genomic DNA and EcoTaq 
DNA polymerase (Ecogen, Barcelona, Spain). The fragment was digested with 
HindIII and KpnI and cloned into the integrative vector pRV300 (Leloup et al. 
1997) treated with the same enzymes. The resulting plasmid, pRVfbp, was 
transformed by electroporation into BL23 strain by using a Gene-Pulser (Biorad) 
as previously described (Posno et al. 1991) and transformants were selected in 
solid media by erythromycin resistance. Integration at the correct locus and 
fbpA disruption was checked by southern blot on HindIII-digested genomic 
DNA. The probe was the pRVfbp insert labelled with digoxigenin (DIG) with the 
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PCR DIG-labeling mix (Roche). Hybridization and detection was performed in 
Hybond-N membranes (GE Healthcare) by using alkaline phosphatase-
conjugated anti-DIG and the CDP-star chemiluminiscent reagent as 
recommended by the manufacturer (Roche). The insertional mutation was 
shown to be stable for at least ~40 generations in the absence of antibiotic 
(screening of 600 colonies after two consecutive overnight cultures gave a 
100% of erythromycin resistants). Therefore, to discard interferences resulting 
from growth with antibiotics, bacteria used for the binding experiments in Figure 
2A and for growth curves were grown in the absence of erythromycin.  
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Microtitre plate binding assays 
Binding of L. casei to immobilized human fibronectin (Sigma) was performed in 
96-well Polysorp plates (Nunc) with bacterial cells grown to late exponential 
phase (OD550 of 3.5-4; 1.2x109 to 1.4x109 cfu ml-1). Plates were covered with 
50 μg ml-1 of fibronectin in carbonate/bicarbonate buffer 50 mmol l-1 pH 9.6 at 
4ºC overnight. Wells were washed three times with PBS and blocked for 1 h 
with PBS plus 1% Tween 20. One hundred μl of each strain were added to each 
well in PBS adjusted to an OD550nm of 1 (7x108 cfu ml-1) and plates were 
incubated overnight at 4ºC. After removing non-adhered cells by three washes 
with 200 μl of PBS plus 0.05% Tween 20 (PBST), the plates were dried and 
adhered cells were detected by staining with crystal violet (1mg ml-1 for 45 min). 
After washing, the colorant was released with citrate buffer 50 mmol l-1 pH 4.0 
(100 μl per well) and the absorbance at 595nm was determined in a Multiskan 
Ascent plate reader (Thermo-Labsystems, Helsinki, Finland). The effect of 
protease treatment was assayed by incubating bacterial cells at an OD550nm of 
1 (7x108 cfu ml-1) in PBS with 100 μg ml-1 of proteinase K (Roche) at 37ºC for 1 
h. After incubation, the protease was inactivated by addition of 1 mmol l-1 
phenylmethylsulfonyl fluoride followed by three washes with PBS containing 1 
mmol l-1 phenylmethylsulfonyl fluoride. Bacteria were resuspended in PBS to an 
OD550nm of 1 (7x108 cfu ml-1) and used for binding assays. Control bacterial 
cells were treated exactly as digested bacterial cells but without the addition of 
proteinase K. Inhibition of binding by soluble fibronectin was assessed by 
adding different quantities of fibronectin (1 to 10 μg per well) to the binding 
assay described above. Blank wells without bound fibronectin were run as 
controls in all experiments and their absorbance values were subtracted from 
the values of wells covered with fibronectin. Experiments were carried out in 
triplicate three times with bacteria coming from independent cultures. 
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For whole-cell ELISA analysis, L. casei bacterial cells were bound to 
immunoplates in PBS buffer at an OD550nm of 0.1 overnight at 4ºC. The wells 
were washed and blocked with 2% BSA in PBS and the content of the wells 
were reacted with a 1:200 dilution of anti-FbpA mouse serum or preimmune 
serum followed by a 1:1000 dilution of peroxidase-conjugated anti-mouse IgG. 
Color was developed with the 1-StepTM Ultra TMB-ELISA substrate (Pierce). 
To assay binding to soluble fibronectin, L. casei bacterial cells at an OD550nm 
of 1 (7x108 cfu ml-1) were incubated with 100 to 500 ng of fibronectin in 1 ml of 
PBST containing 1% BSA for 1 h at 37ºC. After three washes with PBST, bound 
fibronectin was released by boiling the bacteria in SDS-PAGE buffer and 
detected by western blotting with a rabbit anti-fibronectin serum (Sigma). 
Adhesion to solvents test 
Microbial adhesion to solvent (MATS) test has been used to asses the surface 
properties of lactobacilli (Vinderola et al. 2004). This test was performed with L. 
casei essentially as described (Bellon-Fontaine et al. 1996). Five ml of overnight 
cultures of each strain were washed with PBS and resuspended in PBS to a 
final OD600nm of 0.4 (A0). This suspension was mixed (1:3) with different 
solvents (chloroform, ethyl-acetate or hexadecane) and vortexed for 1 min at full 
speed. After phase separation, absorbance of the aqueous phase was 
measured at 600nm (A1). The percentage of adhesion was calculated from: 
%Adhesion=100X[1-(A1/A0)]. Each experiment was done in triplicate with 
bacteria coming from independent cultures. 
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Adhesion to Caco-2 and HT-29 cell lines 
Epithelial cells were seeded at 4x104 cells cm-2 (Caco-2) or 2x105 cell cm-2 (HT-
29) in 24-well plates in DMEM medium (with Glutamax, glucose 25 mM; Gibco) 
supplemented with 1%(v/v) non-essential amino acids solution (Gibco), 1%(v/v) 
sodium pyruvate solution (Gibco), 1%(v/v) sodium bicarbonate solution (Gibco, 
only for HT-29 cells), 1% (v/v) of antibiotics (100 U ml-1 penicillin, 100 μg ml-1 
streptomycin, Gibco)  and 10%(v/v) fetal calf serum and incubated at 37ºC in a 
CO2 incubator. After the cells reached confluence (incubation for 6 and 3 days 
for Caco-2 and HT-29, respectively), plates were incubated for additional 15 
(Caco-2) or 21 (HT-29) days to allow cell differentiation and the medium was 
changed every two days. Log-phase L. casei bacterial cells were added to each 
well in 0.5 ml of culture medium adjusted to an OD550nm of 0.2 (108 cfu ml-1) 
and the plates were incubated for 1 h at 37ºC with mild agitation. Non-adhered 
bacteria were removed by washing 3 times with 1 ml of PBS and the bacteria 
were detached by covering the monolayer with 200 μl of a 15% (v/v) solution of 
trypsin-EDTA (Gibco) in PBS. After addition of 300 μl of culture medium, serial 
dilutions were plated on MRS agar plates and the bacterial colonies were 
counted after 48 h of incubation. The experiments were made in triplicate three 
times with bacteria coming from independent cultures. Adhesion was expressed 
as percentage of adhered bacteria respect to input bacteria. 
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Purification of 6X(His)FbpA and binding assays 
The L. casei BL23 fbpA gene was amplified with oligonucleotides FBP3 (5’-
CGGGGATCCATGTCATTTGACGGAATC) and FBP4 (5’-
ACGAAGCTT
6 
TTACTTGGTAGGCGGGTTGC) which included restriction sites 
(underlined) and Pfx DNA polymerase (Invitrogene). The amplified fragment 
was digested with BamHI and HindIII and cloned into the expression vector 
pQE30 (Qiagen) digested with the same enzymes. The plasmid construct was 
transferred to E. coli M15[pREP4] and cells of the transformed strain were 
grown in 500 ml of LB medium at 37ºC until OD550nm reached 0.6. Then, IPTG 
was added to 1 mmol l-1 and induction was carried out for 3 h at 37ºC. Cells 
were collected by centrifugation, washed and resuspended in 10 ml of Tris-HCl 
100 mmol l-1 pH7.4, lysozyme 1 mg ml-1, phenylmethylsulfonyl fluoride 0.5 mmol 
l-1, dithiothreitol 0.5 mmol l-1 and disrupted by sonication. The cellular debris 
were eliminated by centrifugation at 6000xg for 30 min at 4ºC, the supernatant 
containing recombinant 6X(His)FbpA was applied to a Ni-NTA column (Qiagen, 
1 ml bed volume) and the recombinant protein purified according to the 
instructions of the manufacturer. Fractions containing 6X(His)FbpA were 
analyzed by SDS-PAGE and dialyzed overnight at 4ºC in Tris-HCl 50 mmol l-1 
pH8, EDTA 1 mmol l-1, NaCl 500 mmol l-1, glycerol 15% and stored at -80ºC 
until use. Protein concentrations were determined with the BioRad dye-binding 
assay. To test in vitro fibronectin binding of FbpA, different protein amounts of 
6X(His)FbpA were added in 100 μl of PBS buffer plus 0.1% BSA to microwell 
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plates covered with fibronectin or BSA (50 μg ml-1 in carbonate/bicarbonate 
buffer 50 mmol l-1 pH9.6, overnight at 4ºC). After 1 h of incubation at 37ºC, 
unbound protein was removed by washing 3 times with PBST and His-tagged 
FbpA was detected with the HisProbeTM-HRP reagent (Pierce) and 1-StepTM 
Ultra TMB-ELISA (Pierce) as recommended by the manufacturer. 
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Preparation of antiserum to 6X(His)FbpA 
Fifteen micrograms of purified 6X(His)FbpA were intraperitonially administered 
to 8-weeks old female Balb/c mice (kept at the animal facilities of the University 
of Valencia) in 50 μl of PBS containing adjuvant. Three doses were applied at 
two weeks intervals. Ten days after the last administration, mice were bled and 
the presence of anti-FbpA antibodies in sera was tested by western-blot.  
Isolation of cellular fractions and western blot 
L. casei bacterial cells were grown in 50 ml of MRS to late exponential phase 
(OD550nm of 3.5-4; 1.2x109 to 1.4x109 cfu ml-1) and washed two times with 
PBS. The pellet was resuspended in Tris-HCl 10 mmol l-1 pH8, LiCl 1.5 mol l-1 
and incubated at 4ºC for 1 h. Bacteria were pelleted by centrifugation at 6000xg 
for 10 min and proteins in the supernatant were precipitated by adding 
trichloroacetic acid to 10% and incubation at 4ºC for 1 h, followed by 
centrifugation at 10.000xg 20 min, washing with cold 96% ethanol and 
resuspension of the pellet in urea 7 mol l-1.  The cell pellet was disrupted with 
glass beads (0.1 mm) in a Mini-Bead Beater (BioSpec Products, Bartlesville, 
OK, USA ) with four cycles of 30 s at maximal speed and unbroken cells were 
discarded by centrifuging the supernatant three times at 6000xg for 5 min. The 
supernatant was then centrifuged at 22.000xg, 20 min at 4ºC. The soluble 
fraction was retained as the cytoplasm fraction, whereas the pellet was washed 
three times at 22.000xg for 15 min with Tris-HCl 50 mmol l-1 pH8 plus NaCl 0.5 
mol l-1 and retained as the cell-envelope fraction (cell-wall/membrane 
fragments). To asses the effect of protease digestion on LiCl extraction of FbpA, 
before extraction the bacteria were treated with protease as described above. 
Samples of the different fractions were separated by 10% SDS-PAGE and the 
gels were electro-transferred to Hybond-ECL membranes (GE Healthcare). 
FbpA was detected with a mouse anti-FbpA serum (1:5000) and the ECL-
advance western blotting detection kit (GE Healthcare). 
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Statistical analysis. 
Results are indicated as means ± standard deviation. The significance of the 
difference of the means in experiments carried out with wild-type L. casei and 
the fbpA mutant was calculated by the Student´s t-test with the PRISM 4.0 
software (Graph Pad Software, San Diego, CA, USA). 
RESULTS 1 
2 Characterization of an L. casei BL23 strain mutated in fbpA 
Inspection of the L. casei BL23 genomic sequence (Genbank FM177140) 3 
revealed the presence of a gene (LCABL_16620, designated fbpA from now), 
which encoded a protein showing homology to FBP54 (46% identity) or PavA 
(43% identity) from Streptococcus pyogenes and S. pneumoniae, respectively, 
two proteins which have been reported to mediate fibronectin binding (Courtney 
et al. 1994; Holmes et al. 2001). The product of fbpA was a 64-kDa protein 
which contained the typical pfam05833 and pfam05670 domains (Pfam 
database) present in a variety of bacterial fibronectin-binding proteins. In order 
to construct a mutant affected in fbpA, an internal fragment of the gene was 
cloned into the non-replicative plasmid pRV300. Electroporation of this 
construct (pRVfbp) in BL23 yielded erythromycin-resistant clones in which the 
plasmid was integrated at the fbpA locus leading to a disruption of the gene 
(Figure 1). One of such integrants was chosen and designated BL308 
(fbpA::pRV300). Compared to the wild type, the fbpA mutant showed a reduced 
specific growth rate (0.320±0.005 and 0.290±0.01 h-1 for BL23 and BL308 
strains, respectively; P=0.0217). Both strains were able to bind fibronectin 
immobilized on immunoplates in a protease-sensitive manner, as treatment of 
the cells with proteinase K drastically reduced the binding (Figure 2A). 
Interestingly, the presence of the fbpA mutation produced a 50% reduction in 
binding (P=0.004) to immobilized fibronectin compared to the wild type (Figure 
2A). Adding soluble fibronectin to the binding assays resulted in a decrease of 
bacterial binding in both the wild type and the fbpA mutant, suggesting that L. 
casei BL23 was interacting with immobilized as well as soluble fibronectin 
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(Figure 2B). This latter idea was confirmed by incubating L. casei cells with 
fibronectin. After several washings, fibronectin attached to the cell surface could 
be released and detected by immunoblotting (Figure 2C). In these assays, no 
differences between the wild-type and the fbpA mutant were observed and 
protease treatment reduced the binding in both strains (Figure 2C). In 
conclusion, the attachment ability to immobilized as well as soluble fibronectin 
probably involved surface proteinaceous substances and FbpA played a role in 
attachment to the immobilized form.  
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Two other tests were performed in order to detect changes in cell surface 
characteristics induced by the fbpA mutation. First, we measured adhesion of 
the strains to cultured intestinal epithelial cells lines. A small but significant 
increase in adhesion to the HT-29 cell line was observed in the fbpA mutant 
strain with respect to the wild type (% adhesion of 3.03±0.7 and 4.11±1.8 for the 
wild type and the fbpA mutant, respectively; P=0.02), whereas no significant 
changes were detected in the binding ability to Caco-2 (% adhesion of 0.96±0.6 
and 1.3±0.34 for the wild type and the fbpA mutant, respectively; P=0.167). As a 
second approach we used the microbial adhesion to solvent test (MATS) with 
three different solvents: chloroform (acidic solvent and electron acceptor); ethyl-
acetate (basic solvent and electron donor) and hexadecane (hydrophobic 
solvent). The results showed that the fbpA mutation did not induce changes in 
the acid-base characteristics of the cell surface; however, fbpA-disrupted cells 
showed a clear diminishing in their hydrophobicity, as reflected by a 70% 
decrease in the affinity for hexadecane (Figure 3). 
 
L. casei FbpA binds to fibronectin 
The fbpA gene was cloned in E. coli and FbpA was purified after expression as 
a His-tagged protein. When the purified protein was tested for binding to 
fibronectin immobilized on immunoplates, it was shown that 6X(His)FbpA bound 
to fibronectin in a dose-dependent and saturable manner. A low binding was 
observed when the immunoplates were covered with the control protein BSA 
(Figure 4A). In inhibition experiments where soluble fibronectin was added to 
the binding reaction, a low inhibition (around 20%) in FbpA binding was only 
found at the highest fibronectin concentration (Figure 4B). These results were in 
agreement with the previous characterization of the L. casei fbpA mutant and 
those reported for the S. pneumoniae protein (Holmes et al. 2001), which 
showed that FbpA preferentially binds to immobilized fibronectin. 
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Cellular location of FbpA 
To address the question whether FbpA was present at the L. casei cell surface 
several L. casei fractions were tested by western blot against an anti-FbpA 
serum. Results showed that a 64-kDa band, the molecular weight of FbpA, was 
detected in all cellular fractions (surface proteins extracted with LiCl, cell-
envelope proteins and cytoplasmic proteins, Figure 5A). Additional unspecific 
bands were also shown to react with the antiserum. These bands were not 
detected in the LiCl fraction, indicating the absence of cross-contamination. The 
64-kDa band disappeared in the fbpA-disrupted mutant (Figure 5B), thus 
confirming its identity as FbpA. Similar amounts of extracted proteins were 
loaded onto each lane, which led us to the conclusion that most of FbpA was 
present intracellularly. Treatment of the cells with protease reduced the amount 
of FbpA extracted by LiCl treatment, reinforcing the idea that part of FbpA is 
surface-exposed and accessible to hydrolytic enzymes (Figure 5C). However, 
similar to the rest of homologue proteins, no signal peptide responsible for 
protein secretion was identifiable in the FbpA sequence. 
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FbpA in other L. casei strains 
We screened a collection of L. casei strains from different origins (food and 
human isolates, including probiotic strains, Table 1) for the presence of FbpA. 
As expected from the presence of a gene homologous to fbpA in its genome 
(LSEI_1439), the BL90 (ATCC334) strain showed a reacting protein band 
similar to BL23 (Figure 5). FbpA homologue proteins were also extracted at 
different levels by LiCl treatment in the rest of L. casei strains and were also 
present in the corresponding surface fractions (Figure 6). The cross-reacting 
bands varied in size, indicating that FbpA from different L. casei strains are not 
totally identical. Furthermore, southern blot hybridization with an fbpA probe 
showed that a single copy of fbpA was present in all strains (data not shown).  
Whole-cell ELISA analysis, in which the bacterial cells were bound to microtitre 
plates and probed with the anti-FbpA serum, led also to the detection of FbpA 
(Figure 7). These results concluded that the presence of FbpA on the cell 
surface is a common feature in L. casei. 
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In this work we tried to get some insight into the mechanisms which mediate 
interactions of lactobacilli to host cells. To this end, we have characterized FbpA 
from L. casei, a protein homologous to fibronectin-binding proteins described in 
other bacteria. Genome search at the NCBI database revealed that all 
sequenced lactobacilli genomes encode FbpA homologues with amino acid 
identities ranging from 41 to 60% compared to L. casei FbpA. In the search for 
host adhesion factors in L. acidophilus NCFB, Buck et al. (Buck et al. 2005) 
constructed a mutant in fbpA which displayed a strong reduction in Caco-2 cells 
attachment. These experiments established that L. acidophilus FbpA 
participates in adhesion to epithelial cells. Nevertheless, no assays on 
fibronectin binding were carried out in this study. Contrarily to what was 
expected, our results showed that, compared to the wild type, L. casei fbpA 
strain adhered slightly better to HT-29 cells, whereas no significant changes 
were detected on Caco-2 adherence. This striking result suggests that changes 
in the bacterial surface resulting from an fbpA mutation (as evidenced by 
decreased surface hydrophobicity) lead to a slightly improved capacity to attach 
to HT-29 cell surfaces. However, the reason for this observation is not known. 
L. casei probably utilizes other FbpA-independent mechanisms for attachment 
to the HT-29 and Caco-2 cell lines or the contribution of FbpA to binding in 
these models is low. It has been reported that FBP54, an FbpA homologue from 
S. pyogenes, had minor effects on binding to some types of epithelial cells, 
whereas binding to others was strongly influenced by this adhesin (Courtney et 
al. 1996). 
Similar to fbpA-mutated streptococci, where reduction of bacterial fibronectin 
binding ranged from 50 to 25% (Christie et al. 2002; Miller-Torbert et al. 2008), 
disruption of L. casei fbpA led to only a 50% reduction in binding. This 
strengthens the idea that adhesion is a multifactor process and suggests the 
presence of additional not yet identified fibronectin-binding molecules, 
presumably of proteinaceous nature. In any case, inspection of the BL23 
genome does not reveal the presence of genes encoding other types of 
fibronectin-binding proteins.  
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Previous studies showed that some lactobacilli were able to bind to the 
immobilized but not to the soluble form of fibronectin (Lorca et al. 2002). We 
showed that L. casei BL23 can bind both forms of fibronectin but FbpA is 
binding more efficiently to only the immobilized form. The FbpA proteins belong 
to an atypical group of fibronectin-binding proteins which lack the repetitive, 
secretion and cell-wall anchoring (LPXTG motif) sequences present in other 
characterized fibronectin-binding proteins (Jedrzejas 2007). Lack of 
conventional signal for secretion and anchoring is a common feature of 
numerous proteins which decorate the bacterial surface. In lactobacilli, many of 
the characterized attachment factors are surface “moonlighting” proteins that 
are implicated in other processes. These include the elongation factor Tu (EF-
Tu) (Granato et al. 2004), the heat shock protein GroEL (Bergonzelli et al. 2006) 
and glycolytic enzymes (Hurmalainen et al. 2007; Kinoshita et al. 2008; Ramiah 
et al. 2008). How these proteins are transported and localized at the cell surface 
is still unknown. 
Although L. casei FbpA can be found at the cell surface, the vast majority of the 
protein was of intracellular location. Similar results were found for the 
homologue protein Fbp68 from Clostridium difficile (Hennequin et al. 2003). 
Despite of the fact that all FbpA-homologues characterized to date have a 
surface location, posses in vitro binding ability to fibronectin and are important 
virulence factors in pathogens (Dramsi et al. 2004; Holmes et al. 2001), some 
controversy exists about the exact role of FbpA. In S. gordonii, fbpA is clustered 
with a gene (cshA) encoding a distinct fibronectin-binding protein whose 
expression is down-regulated upon fbpA mutation, for which it was postulated 
that FbpA might play a role in the transcriptional regulation of adhesion factors 
(Christie et al. 2002). Likewise, a mutation in fbpA of Listeria monocytogenes 
reduces the amount of two virulence factors (listeriolysin O and InlB) acting at 
the post-transcriptional level and FbpA co-precipitates with them, therefore it 
was postulated that it might function as a chaperone or an escort protein for 
these factors (Dramsi et al. 2004). The genome context of fbpA in L. casei BL23 
does not allow prediction of putative functions for FbpA. The fbpA gene is 
monocistronic and no adhesion-related genes can be found adjacent to it. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
The pleiotropic effects of fbpA mutations largely differ between species. S. 
pneumoniae pavA (fbpA) mutants bound less to fibronectin and were attenuated 
in virulence, however, they showed no changes in cell surface physicochemical 
properties or in the expression of virulence factors (Holmes et al. 2001). A 
different situation was found in S. gordonii (Christie et al. 2002) and in L. casei 
BL23 fbpA mutants, where a clear decrease in the cell surface hydrophobicity 
was observed. In S. gordonii this decrease was related to the lower expression 
of CshA (Christie et al. 2002). Further research is needed to disclose the 
changes produced by an fbpA mutation on the cell surface of L. casei BL23. 
Whether FbpA directly interacts with fibronectin in vivo or it modulates the 
expression and functionality of other interacting proteins, or both, is still 
unknown. 
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It has been reported that the adhesive capacity of lactobacilli to ECM proteins is 
not exclusively found in probiotics or human isolates (Vesterlund et al. 2007). 
Therefore, no link between attachment and probiotic character appears to exist. 
FbpA orthologues are encoded in the genomes of all sequenced lactobacilli and 
the protein can be extracted from the cell surface of all L. casei strains tested in 
this work, from both human and food origin. While the exact role of FbpA in 
either pathogen, commensal or probiotic bacteria is not yet understood, the 
study of this protein in lactobacilli may lead to a better understanding of the 
relations established between  these bacteria and the intestinal epithelium. 
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2 Table 1. L. casei strains used in this study 
strain origin/reference selected characteristics 
BL23 CECT* 5275 laboratory strain; sequenced genome 
(Acedo-Félix and Pérez-Martínez 2003) 
BL32 CECT4040 cheese isolate 
BL82 ATCC† 25598 sour milk isolate 
BL83 CECT4043 cheese isolate 
BL87 ATCC11578 oral cavity isolate 
BL90 ATCC334 cheese isolate; sequenced genome 
BL91 ATCC4545 dental caries isolate 
BL101 laboratory stock isolated from commercial probiotic drink 
BL106 laboratory stock isolated from commercial probiotic drink 
BL193 laboratory stock isolated from commercial probiotic drink 
BL199 CRL‡ 87  exopolysaccharide producer (Mozzi et al. 
1996) 
BL208 laboratory stock human intestinal isolate 
BL212 CRL686 dry cured sausage isolate (Fadda et al. 
1998) 
BL227 laboratory stock commercial probiotic 
BL229 laboratory stock commercial probiotic 
BL308 BL23 fbpA::pRV300, eryr this work 
*Colección Española de Cultivos Tipo; †American Type Culture Collection; ‡Centro de 
Referencia para Lactobacilos; eryr, erythromycin resistant. 
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Figure 1 
Construction of an L. casei BL23 mutant in fbpA. (A) Wild-type strain was 
transformed with the non-replicative pRVfbp plasmid and erythromycin-resistant 
colonies were selected. (B) Integration at the correct locus was verified by 
southern blot on HindIII-digested genomic DNA from wild-type strain (BL23) 
and the disrupted mutant (BL308). 
Figure 2 
Binding of L. casei to fibronectin. (A) Effect of protease treatment and fbpA 
disruption on L. casei binding to immobilized fibronectin; (B) Inhibition of L. 
casei binding to immobilized fibronectin by soluble added fibronectin, (C) 
Binding of L. casei to soluble fibronectin. Cells were incubated with fibronectin, 
washed and bound fibronectin was detected by western-blot. In parallel 
experiments, cells were treated with protease prior to fibronectin binding 
assays. BL23 is wild-type L. casei; BL308 is the fbpA mutant strain. The bars 
represent standard deviations. 
Figure 3 
Cell-surface characteristics of L. casei wild type (BL23) and the fbpA mutant 
(BL308) measured by the MATS test. The bars represent standard deviations. 
Figure 4 
Binding of purified FbpA. (A) Binding of 6X(His)FbpA to fibronectin immobilized 
on immunoplates. After washing, the bound protein was detected with a His-tag 
detection reagent; (B) Inhibitory effect of soluble fibronectin on 6X(His)FbpA 
binding. The bars represent standard deviations. 
Figure 5 
Detection of FbpA at the cell surface. (A) Western blot detection of FbpA in 
different cellular fractions of L. casei wild type (BL23). One μg of extracted 
proteins was loaded onto each lane. LiCl, surface proteins extracted with LiCl; 
E, surface proteins from the cell-envelope (cell-wall/membrane fraction); C, 
cytoplasmic proteins; (B) Detection of FbpA in cell extracts (1 μg total protein 
per lane) of L. casei BL23 and the fbpA mutant (BL308); (C) The effect of 
protease digestion on the LiCl extraction of FbpA from L. casei BL23. 
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Figure 6 
Detection of FbpA in different L. casei strains. Equal amount of LiCl-extracted 
proteins (equivalent to the protein extracted from 10 absorbance units (600nm) 
of cells) (A) and one μg of cell-envelope proteins (B) were resolved by 10% 
SDS-PAGE and tested by western-blot with an anti-FbpA serum. 
Figure 7 
Whole-cell ELISA analysis to detect the presence of FbpA on the surface of L. 
casei strains. Bacterial cells were bound to the surface of immunoplates and an 
ELISA test was carried out with an anti-FbpA serum. Data presented are 
subtracted from the absorbance values of control wells incubated with a pre-
immune serum. The bars represent standard deviations  
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